Company Research Report: VIDA Diagnostics Inc.

Company Overview

Name

VIDA Diagnostics Inc.

Mission

VIDA is a precision lung health company whose mission is to accelerate therapies to patients through AI-powered lung intelligence, enabling more efficient respiratory clinical trials with precise quantitative endpoints and AI-powered data quality controls.

Founded

VIDA was founded in 2004.

Key People

• Susan Wood, PhD: Chief Executive Officer - Over 25 years of experience in clinical solutions, with a Ph.D. from Johns Hopkins Medical Institutions.

• Sandra Stapleton, MSc: Chief Operating Officer - Over 20 years of experience in operational and engineering functions.

• Todd Johnson, MBA: Chief Technology Officer - Over 25 years in clinical imaging and healthcare IT industries.

• Joe Reif, MBA: Vice President of Clinical and Business Development.

• Marcel Nienhuis, MBA: Vice President of Marketing.

• Margaret Cranston, MBA: Vice President, Commercial Operations.

• John Newell Jr, MD: Medical Director - Renowned Professor of Radiology and Biomedical Engineering.

Headquarters

2500 Crosspark Road, W250 BioVentures Center, Coralville, Iowa 52241, USA.

Number of Employees

The company has between 51-200 employees.

Revenue

No information is available.

Known For

VIDA is known for modernizing lung and respiratory care through artificial intelligence, providing solutions for chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), asthma, emphysema, lung cancer, and COVID-19. VIDA is a leader in AI-powered lung intelligence, focusing on respiratory clinical trials and patient care.

Products

VIDA Discovery

VIDA Discovery services enhance respiratory clinical trials with more precise quantitative endpoints and data quality controls. These services improve efficiency, cut costs for biopharma sponsors, and provide site training.

Key Features:

• Provides quantitative lung imaging biomarkers.

• Optimizes imaging operations.

• Supports data-driven clinical trials.

VIDA Insights

VIDA Insights empowers physicians to manage patients with chronic lung diseases more effectively.

Key Features:

• AI-powered data insights.

• Precision imaging to support diagnosis and treatment.

• Provides a richer set of quantitative CT lung information.

Recent Developments

New Products/Features

• VIDA Launches VIDA Intelligence Portal 2.0: This new portal is designed to accelerate onboarding of clinical trial sites.

• VIDA Launches Cloud-Based Case Viewer: This development aims to improve clinical trial imaging workflows.

• VIDA Introduces AI-Enabled Biomarker Services: Expanding their service offerings with new biomarker capabilities.

New Partnerships

• Partnership with Polarean to streamline advanced MRI of the lungs.

• Collaboration with RAYUS Radiology to empower imaging sites for decentralized clinical trials.

• Expansion into Japan through partnership with Clairvo.

Key Achievements

• Named as one of the fastest-growing private companies in the US.

• Global footprint expanded beyond 1,000 sites.

• Obtained 510(k) clearance for LungPrint® solution with deep learning-based enhancements.

• Announced strategic investment from UnityPoint Health Ventures.

Other Developments

• Completed a second close of Round C financing to accelerate AI-powered lung imaging analysis.

• VIDA's AI solutions are being implemented across UnityPoint Health system to modernize lung and respiratory care.

This report highlights VIDA Diagnostics Inc. as an emerging leader in the medical imaging sector, leveraging AI and advanced imaging technologies to transform respiratory care.